Ethyl 2-(benzo[d][1,3]dioxol-5-yl)thiazole-4-carboxylate, 95.0%, 250mg

3-Methyl-1-phenyl-1h-pyrazol-5-amine hydrochloride, 95%, 100g

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

N-4-Phenylasparagine, 95.0%, 5g

[1-(4-methoxy-3-methylphenyl)ethyl]amine hydrochloride, 95.0%, 250mg

3,4-Dichlorophenacyl Bromide>98.0%(GC)25g

2,6-Dichloro-4-fluorobenzoic acid, 95.0%, 1g

3-(4-(3-(Trifluoromethyl)-3H-diazirin-3-yl)phenyl)propanoic acid, 97%, 1g

ETHYL 4-([4-(DIETHYLAMINO)PHENYL]AMINO)-6-METHYLQUINOLINE-3-CARBOXYLATE, 95%, 50mg

2,3-Benzodiazine, 97.0%, 1g

Adamantane-1,3-diamine dihydrochloride, 95.0%, 250mg

(1R,2R)-2-Fluorocyclohexanamine hydrochloride, 95%, 500mg

1-Methyl-1H-pyrazole-4-carboxylic acid hydrazide, 95.0%, 1g